Membres du groupe

Prof. Julius Popp
Chef de groupe
Téléphone : +41 22 305 50 13
Courriel

Professeur associé, Département de psychiatrie, Faculté de médecine UNIGE
Médecin-chef du service de psychiatrie gériatrique, HUG

Julius Popp est psychiatre et psychothérapeute. Après un doctorat de médecine obtenu à l’Université de Tübingen, en Allemagne, il se spécialise en psychiatrie à Bonn.  Arrivé en Suisse, il occupe les fonctions, de 2010 à 2017, de médecin chef de clinique puis de médecin associé dans le Service de psychiatrie de l’âge avancé du CHUV, à Lausanne, où il est également chef d’un groupe de recherche.  Sur le plan académique, il est nommé en 2012 maître d’enseignement et de recherche en psychiatrie gériatrique à l’Université de Lausanne, puis privat-docent en 2013 au sein de la même institution.

Depuis octobre 2017, Julius Popp est médecin-chef du Service de psychiatrie gériatrique au Département de santé mentale et de psychiatrie des HUG, et professeur associé au Département de psychiatrie de la Faculté de médecine de l’UNIGE. Ses activités de recherche visent à mieux comprendre les troubles cognitifs et neuropsychiatriques chez les personnes âgées, à améliorer leur prédiction et leur diagnostic précoce, ainsi qu’à développer de nouvelles stratégies préventives et thérapeutiques.

Publications

Original articles

Bitzer M, Opitz H, Popp J, Morgalla M, Gruber A, Heiss E, Voigt K. Angiogenesis and brain oedema in intracranial meningiomas: influence of vascular endothelial growth factor. Acta Neurochir (Wien). 1998;140(4):333-40.

Milhaud D, Popp J, Thouvenot E, Heroum C, Bonafé A. Mechanical ventilation in ischemic stroke. Journal of Stroke and Cerebrovascular Diseases. 2004; 13(4):183-188

Popp J, Thal D, Lewczuk P, Wiltfang J, Jessen F. Histologically confirmed amyloid deposition and low CSF Abeta (42) in a cognitively normal subject. J Neurol. 2007 Mar 14

Schaper K, Kölsch H, Popp J, Wagner M, Jessen F. KIBRA   gene   variants   are   associated   with   episodic   memory   in   healthy   elderly. Neurobiol Aging. 2007 Mar 10

Popp J, Michael R, Freymann K, Jessen F. Diagnostic lumbar puncture performed in the outpatient setting of a memory clinic : Frequency and risk factors of post-lumbar puncture headache. Nervenarzt. 2007 Jun;78(5):547-51.

Qureischie H, Heun R, Lütjohann D, Popp J, Jessen F, Ledschbor-Frahnert C, Thiele H, Maier W, Hentschel F, Kelemen P, Kölsch H. CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk. Brain Res. 2008 Sep 26;1232:1-6.

Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Bürger K, Hampel H, Frölich L, Wolf S, Prinz B, Jahn H, Luckhaus C, Perneczky R, Hüll M, Schröder J, Kessler H, Pantel J, Gertz HJ, Klafki HW, Kölsch H, Reulbach U, Esselmann H, Maler JM, Bibl M, Kornhuber J, Wiltfang J. Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry. 2008 Jul 29

Popp J, Schaper K, Kölsch H, Cvetanovska G, Rommel F, Klingmüller D, Dodel R, Wüllner, U, Jessen F. CSF cortisol in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging. 2009 Mar;30(3):498-500.

Hong GS, Heun R, Jessen F, Popp J, Hentschel F, Kelemen P, Schulz A, Maier W, Kölsch H. Gene variations in GSTM3 are a risk factor for Alzheimer's disease. Neurobiol Aging. 2009 May;30(5):691-6.

Kölsch H, Lütjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Schmitz S, Maier W, Heun R. CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism. Eur Psychiatry. 2009 Apr;24(3):183-90.

Kölsch H, Lütjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Friedrichs S, Maier TA, Heun R. RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism. J Cell Mol Med. 2009 Mar;13(3):589-98.

Qureischie H, Heun R, Popp J, Jessen F, Maier W, Schmitz S, Hentschel F, Kelemen P, Kölsch H. Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions. J Neural Transm. 2009 Apr;116(4):467-72.

Popp J, Bacher M, Kölsch H, Noelker C, Deuster O, Dodel R, Jessen F. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease. J Psychiatr Res. 2009 May;43(8):749-53.

Alexopoulos P, Günther F, Popp J, Jessen F, Peters O, Wolf S, Kneib T, Kurz A, Richter- Schmidinger T, Lewczuk P, Bleich S, Wiltfang J, Kornhuber J. Plasma homocysteine and cerebrospinal fluid neurodegeneration biomarkers in mild cognitive impairment and dementia. J Am Geriatr Soc. 2009 Apr;57(4):737-9.

Klafki H, Lewczuk P, Kamrowski-Kruck H, Maler JM, Müller K, Peters O, Heuser I, Jessen F, Popp J, Frölich L, Wolf S, Prinz B, Luckhaus C, Schröder J, Pantel J, Gertz HJ, Kölsch H, Müller BW, Esselmann H, Bibl M, Kornhuber J, Wiltfang J. Measurement of ERK 1/2 in CSF from Patients with Neuropsychiatric Disorders and Evidence for the Presence of the Activated Form. J Alzheimers Dis. 2009;18(3):613-22.

Popp J, Lewczuk P, Linnebank M, Cvetanovska G, Smulders Y, Kölsch H, Kornhuber J, Maier W, Jessen F. Homocysteine metabolism and CSF markers for Alzheimer’s Disease. J Alzheimers Dis. 2009 Dec;18(4):819-28Aug 3.

Guenther U, Popp J, Koecher L, Muders T, Wrigge H, Ely EW, Putensen C. Validity and Reliability of the CAM-ICU Flowsheet to diagnose delirium in surgical ICU patients. J Crit Care. 2009 Oct 12.

Günther U, Wrigge H, Popp J, Andorfer U, Muders T, Putensen C. German short version of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) for routine delirium monitoring. Anästhesiologie & Intensivmedizin. 2009

Bacher M, Deuster O, Aljabari B,  Egensperger R, Neff F, Jessen F, Popp J, Noelker C, Reese JP, Al-Abed Y, Dodel R. The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease.Mol Med. 2010 Mar;16(3-4):116-21.

Striepens N , Scheef L, Wind A, Popp J, Spottke A, Cooper-Mahkorn D, Suliman H, Wagner M,  Schild HH, Jessen F. Volume loss of the medial temporal lobe structures in subjective memory impairment. Dement Geriatr Cogn Disord. 2010;29(1):75-81.

Kölsch H, Heun R, Jessen F, Popp J, Hentschel F, Maier W, Lütjohann D. Alterations of cholesterol precursor levels in Alzheimer’s disease Biochim Biophys Acta. 2010 Aug.

Linnebank M*, Popp J*, Smulders Y, Smith D, Semmler A, Farkas M, Kulic L, Cvetanovska G, Blom H, Stoffel-Wagner B, Kölsch H, Weller M, Jessen F. S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer’s disease. Neurodegener Dis. 2010;7(6):373-8.

* Linnebank and Popp: equal contribution

Popp J, Lewczuk P, Frommann I, Kölsch H, Kornhuber J, Maier W, Jessen F. CSF markers for Alzheimer's Disease over the life span: effects of age and the APOEε4 genotype. J Alzheimers Dis. 2010;22(2):459-68.

Striepens N, Scheef L, Wind A, Meiberth D, Popp J, Spottke A, Kölsch H, Wagner M, Jessen F. Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume. Psychol Med. 2011 Feb 2:1-10.

Vanmierlo T, Popp J, Kölsch H, Friedrichs S, Jessen F, Stoffel-Wagner B, Bertsch T, Hartmann T, Maier W, von Bergmann K, Steinbusch H, Mulder M, Lütjohann D. The plant sterol brassicasterol as additional CSF biomarker in Alzheimer's disease. Acta Psychiatr Scand. 2011 May 17.

Jessen F, Lewczuk P, Gür O, Block W, Ende G, Frölich L, Hammen T, Arlt S, Kornhuber J, Kucinski T, Popp J, Peters O, Maier W, Träber F, Wiltfang J. Association of N-acetylaspartate and cerebrospinal fluid Aß42 in dementia. J Alzheimers Dis. 2011 Aug 12

Wagner M, Wolf S, Reischies FM, Daerr M, Wolfgruber S, Jessen F, Popp J, Maier W, Hüll M, Fröhlich L, Hampel H, Perneczki R, Peters O, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Lewczuk P, Kornhuber J, Wiltfang J. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer’s Disease. Neurology. 2012 Jan 11.

Lewczuk P*, Popp J*, Lelental N, Maier W, Kornhuber J, Jessen F. Cerebrospinal fluid soluble Amyloid Precursor Proteins as potential novel biomarkers of Alzheimer's disease. J Alzheimers Dis. 2011 Oct 4.

*Lewczuk and Popp: equal contribution

 Guenther U, Weykam J, Andorfer U, Theuerkauf N, Popp J, Ely EW, Putensen C. Implications of objective vs subjective delirium assessment in surgical intensive care patients. Am J Crit Care. 2012 Jan;21.

Noelker C, Schwake M, Balzer-Geldsetzer M, Bacher M, Popp J, Schlegel J, Eggert K, Oertel WH, Klockgether T, Dodel RC. Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease. Neurosci Lett. 2012 Jan 17

Arlt S, Schwedhelm E, Kölsch H, Jahn H, Linnebank M, Smulders Y, Jessen F, Boeger RH, Popp J. Dimethylarginines, Homocysteine Metabolism, and Cerebrospinal Fluid Markers for Alzheimer's Disease. J Alzheimers Dis. 2012;31(4):751-8

Smith D, Smulders Y, Blom H, Popp J, Jessen F, Semmler A, Farkas M, Linnebank M. Determinants of the essential one-carbon metabolism metabolites, homocysteine, S- adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid. Clin Chem Lab Med. 2012 Mar 24;50(9):1641-7

Rogacev KS, Pinsdorf T, Weingärtner O, Gerhart MK, Welzel E, van Bentum K, Popp J, Menzner A, Fliser D, Lütjohann D, Heine GH. Cholesterol Synthesis, Cholesterol Absorption, and Mortality in Hemodialysis Patients. Clin J Am Soc Nephrol. 2012 Mar 29.

Scheef L, Spottke A, Daerr M, Joe A, Striepens N, Kölsch H, Popp J, Daamen M, Gorris D, Heneka MT, Boecker H, Biersack HJ, Maier W, Schild HH, Wagner M, Jessen F. Glucose metabolism, gray matter structure and memory decline in subjective memory impairment. Neurology. 2012 Aug 22.

Popp J, Lewczuk P, Kölsch H, Meichsner S, Maier W, Kornhuber J, Jessen F, Lütjohann D. Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's Disease. J Neurochem. 2012 Jul 28.

Guenther U, Theuerkauf N, Frommann I, Brimmers K, Malik R, Stori S, Scheidemann M, Putensen C, Popp J. Predisposing and precipitating factors of delirium after cardiac surgery - a prospective observational cohort study. Ann Surg. 2013 Jun;257(6):1160-7.

Popp J, Meichsner S, Kölsch H, Lewczuk P, Maier W, Kornhuber J, Jessen F, Lütjohann D. Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer’s Disease. Biochem Pharmacol. 2013 Jul 1;86(1):37-42

Dodel R, Rominger A, Bartenstein P, Barkhof F, Blennow K, Förster S, Winter Y, Bach JP, Popp J, Alferink J, Wiltfang J, Buerger K, Otto M, Antuono P, Jacoby M, Richter R, Stevens J, Melamed I, Goldstein G, Haag S, Wietek S, Farlow M, Jessen F. Intravenous immunoglobulins for the treatment of mild to moderate Alzheimer’s disease: a phase II, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2013 Mar;12(3):233-43.

Donati A, Studer J, Petrillo S, Pocnet C, Popp J, Rossier J, von Gunten A. The evolution of personality in Patients with Mild Cognitive Impairment. Dement Geriatr Cogn Disord. 2013 Sep 10;36(5-6):329-339.

Studer J, Donati A, Popp J, von Gunten A. Subjective cognitive decline in patients with mild cognitive impairment and healthy elders: Association with personality traits. Geriatr Gerontol Int. 2013 Aug.

Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A; International Genomics of Alzheimer's Project (IGAP); Alzheimer's Disease Neuroimaging Initiative (ADNI), Heun R, Frölich L, Hüll M, Buscemi L, Herms S, Kölsch H, Scheltens P, Breteler MM, Rüther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, Nöthen MM. SUCLG2 identified as both a determinator of CSF Aβ1-42-levels and an attenuator of cognitive decline in Alzheimer's disease. Hum Mol Genet. 2014 Jul 15

Popp J, Wolfgruber S, Heuser I, Peters O, Hüll M, Schröder J, Möller HJ, Lewczuk P, Schneider A, Jahn H, Luckhaus C, Perneczki R, Fröhlich L, Wagner M, Maier W, Wiltfang J Kornhuber J, Jessen F. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer type. Neurobiol Aging. 2015 Feb;36(2):601-7.

Ewers M, Mattsson N, Minthon L, Molinuevo JL, Antonell A, Popp J, Jessen F, Herukka SK, Soininen H, Maetzler W, Leyhe T, Taniguchi M, Buerger K, Urakami K, Lista S, Dubois B, Blennow K, Hampel H. CSF biomarkers for the differential diagnosis of Alzheimer's disease. A large-scale international multi-venter study. Alzheimers Dement. 2015 Mar 21

Pocnet C, Antonietti JP, Donati A, Popp J, Rossier J, von Gunten A. Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: A two-year follow-up study. Int Psychogeriatr. 2014

Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ; Amyloid Biomarker Study Group, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BN, Bibeau K, Blennow K, Brooks DJ, van Buchem MA, Camus V, Cavedo E, Chen K, Chetelat G, Cohen AD, Drzezga A, Engelborghs S, Fagan AM, Fladby T, Fleisher AS, van der Flier WM, Ford L, Förster S, Fortea J, Foskett N, Frederiksen KS, Freund-Levi Y, Frisoni GB, Froelich L, Gabryelewicz T, Gill KD, Gkatzima O, Gómez-Tortosa E, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Hildebrandt H, Ishihara L, Ivanoiu A, Jagust WJ, Johannsen P, Kandimalla R, Kapaki E, Klimkowicz-Mrowiec A, Klunk WE, Köhler S, Koglin N, Kornhuber J, Kramberger MG, Van Laere K, Landau SM, Lee DY, de Leon M, Lisetti V, Lleó A, Madsen K, Maier W, Marcusson J, Mattsson N, de Mendonça A, Meulenbroek O, Meyer PT, Mintun MA, Mok V, Molinuevo JL, Møllergård HM, Morris JC, Mroczko B, Van der Mussele S, Na DL, Newberg A, Nordberg A, Nordlund A, Novak GP, Paraskevas GP, Parnetti L, Perera G, Peters O, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Resende de Oliveira C, Rinne JO, Rodrigue KM, Rodríguez-Rodríguez E, Roe CM, Rot U, Rowe CC, Rüther E, Sabri O, Sanchez-Juan P, Santana I, Sarazin M, Schröder J, Schütte C, Seo SW, Soetewey F, Soininen H, Spiru L, Struyfs H, Teunissen CE, Tsolaki M, Vandenberghe R, Verbeek MM, Villemagne VL, Vos SJ, van Waalwijk van Doorn LJ, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Zboch M, Zetterberg H. Prevalence of Cerebral Amyloid Pathology in Persons without Dementia: a meta-analysis. JAMA. 2015 May 19;313(19):1924-38. Schaub C, Morin D, Popp J, Von Gunten A. L'agitation chez les personnes atteintes de démence : Examen de la portée des connaissances et mise en perspective du phénomène selon la théorie du confort et le concept de l'attachement. Recherche en soins infirmiers June 2016. 68-83.

Oikonomidi A, Lewczuk P, Kornhuber J, Smulders Y, Linnebank M, Semmler A, Popp J. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta. J Neurochem. 2016 Oct;139(2):324-332.

Lewczuk P, Lelental N, Lachmann I, Holzer M, Flach K, Brandnerd S, Engelborghs S, Teunissen CE, Zetterberg H, Molinuevo JL, Mroczko B, Blennow K, Popp J, Parnetti L, Chiasserini D, Perret-Liaudet A, Spitzer P, Maler JM, Kornhuber J. Non-Phosphorylated Tau as a potential biomarker of Alzheimer's Disease: Analytical and diagnostic characterization. J Alzheimers Dis. 2017;55(1):159-170.

Haba-Rubio J, Marti-Soler H, Tobback N, Andries D, Marques-Vidal P, Waeber G, Vollenweider P, von Gunten A, Preisig M, Castelao E, Tafti M, Heinzer R, Popp J. Sleep characteristics and cognitive impairment in the general population: The HypnoLaus study Neurology 2017 Jan 31;88(5):463-469

Tautvydaitė D, Antonietti JP, Henry H, von Gunten A, Popp J. Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology. J Psychiatr Res. 2017 Feb 4;90:12-20..

Ouanes S, Castelao E, von Gunten A, Preisig M, Popp J. Life events do not explain the link between cortisol and poorer cognition in non-demented subjects: a population-based study. Neurobiol Aging. 2017 Mar;51:1-8. doi

Tautvydaitė D, Kukreja D, Antonietti JP, Henry H, von Gunten A, Popp J. Interaction between personality traits and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology modulates cognitive performance. Alzheimers Res Ther. Feb. 2017.

Popp J, Oikonomidi A, Tautvydaitė D, Dayon L, Bacher M, Migliavacca E, Henry H, Severin I, Kirkland R, Wojcik J, Bowman GM. Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults. Brain, Behavior, and Immunity. 2017 May;62:203-211

Ouanes S, Castelao E, von Gunten A, Preisig M, Popp J. Personality, Cortisol, and Cognition in Non-Demented Subjects: A Population-Based Study. Frontiers in Aging Neuroscience, 2017 Mar 14;9:63

Konz T. Migliavacca E Dayon L Bowman GM, Oikonomidi A, Popp J, Rezzi S. Icp-ms/ms-based ionomics: a validated methodology to investigate the biological variability of the human ionome. Journal of Proteome Research, 2017 May 5;16(5):2080-2090

Dayon L, Oikonomidi A, Migliavacca E, Henry H, Severin I, Kirkland R, Wojcik J, Bowman GM, Popp J. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: Homocysteine and beyond. Alzheimers Res Ther. 2017.

Oikonomidi A, Tautvydaitė D, Gholamrezaee MM, Henry H, Bacher M, Popp J. Macrophage migration inhibitory factor is associated with biomarkers of Alzheimer’s disease pathology and predicts cognitive decline in MCI and mild dementia. J Alzheimers Dis. 2017

Zufferey V, Donati A, Popp J, Meuli R, Rossier J, Frackowiak R, Draganski B, von Gunten A, Kherif F. Traits of neuroticism, depression and anxiety exacerbate state of cognitive impairment and hippocampal vulnerability to Alzheimer’s disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2017.

Dayon L, Wojcik J, Galindo AL, Corthésy J, Cominetti O, Oikonomidi A, , Henry H, Migliavacca E, Bowman GM, Popp J. Plasma proteomic profiles of CSF-defined Alzheimer pathology in older adults. J Alzheimers Dis. 2017

Mathys J, Gholamrezaee M, Henry H, von Gunten A, Popp J. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Exp Gerontol. 2017 Dec 15

Ouanes S, Haba-Rubio J, Popp J. Response to a letter to the editor: sleep disturbance as a stressor event in elderly's life. Neurobiol Aging. 2017 Dec

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H. Association of Cerebral Amyloid-β Aggregation With Cognitive  Functioning in Persons Without Dementia. JAMA Psychiatry. 2018 Jan 1

Mattsson N, Groot C, Jansen W, Landau S, Villemagne V, Engelborghs S, Mintun M, MD; Alberto Lleo A, Molinuevo JM, Jagust W, Frisoni GM, Ivanoiu A, Chetelat G, Prabhakar S, Resende de Oliveira C, Rodrigue KM, Kornhuber A, Wallin A,; Klimkowicz-Mrowiec A, Popp J, The Amyloid Biomarker Study group; Vandenberghe R, David J. Brooks, MD, PhD; Tormod Fladby, MD, PhD; Christopher C. Rowe, MD, PhD; Alexander Drzezga, MD, PhD; Marcel M. Verbeek, PhD; Marie Sarazin, MD, PhD; David A. Wolk, MD; Adam S. Fleisher, MD, MAS; William E. Klunk, MD, PhD; Duk L. Na, MD, PhD; Páscual Sanchez-Juan, MD, PhD; Dong Young Lee, MD, PhD; Agneta Nordberg, MD, PhD; Magda Tsolaki, MD, PhD; Vincent Camus, MD, PhD; Juha O. Rinne, MD, PhD; Anne M. Fagan, PhD; Gil D. Rabinovici, MD; Oskar Hansson, MD, PhD; Wiesje M. van der Flier, PhD; Philip Scheltens, MD, PhD; Pieter Jelle Visser, MD, PhD; & Rik Ossenkoppele. Prevalence of the Apolipoprotein E ε4 allele in amyloid-β positive subjects across the spectrum of Alzheimer’s disease. Alzheimer's & Dementia. 2018, in press

Haba-Rubio J, Ouanes S, Franc Y, Marques Vidal P, Waeber G, Vollenweider P, von Gunten A, Preisig M, Kuehner C, Castelao E, Heinzer R, Popp J. Do diurnal cortisol levels mediate the association between sleep disturbances and cognitive. Neurobiol Aging. 2018 accepted

Reviews

Popp J, Arlt S. Pharmacological treatment of mild cognitive impairment and dementia due to Alzheimer's Disease. Curr Opin Psychiatry. 2011 Nov;24(6):556-61

Monsch AU, Büla C, Hermelink M, Kressig RW, Martensson B, Mosimann U, Müri R, Vögeli S, von Gunten A; Le groupe d'experts en Suisse. Contribution as a group member Consensus 2012-diagnosis and treatment of patients with dementia in Switzerland. Rev Med Suisse. 2013 Apr 17;9(382):838-47.

Popp J, Arlt S. Prevention and treatment options for postoperative delirium in the elderly. Curr Opin Psychiatry. 2012 Nov;25(6):515-21.

Popp J. Delirium and cognitive decline - More than a coincidence. Curr Opin Neurol. 2013 Oct 31.

Savaskan E, Bopp-Kistler I, Buerge M, Fischlin R, Georgescu D, Giardini U, Hatzinger M, Hemmeter U, Justiniano I, Kressig RW, Monsch A, Mosimann UP, Mueri R, Munk A, Popp J, Schmid R, Wollmer MA. Therapy Guidelines for the Behavioural and Psychological Symptoms of Dementia. Praxis (Bern 1994). 2014 Jan 1;103(3):135-48.

Kukreja D, Günther U, Popp J. Delirium in the elderly: current problems with increasing geriatric age. Indian Journal of Medical Research. 2015 Dec

Magnin E, Popp J. Cerebrospinal fluid biomarkers of Alzheimer’s disease in current clinical practice. Rev Med Suisse. 2016

Savaskan E, Baumgartner M, Georgescu D, Hafner M, Hasemann W. Kressig RE, Popp J Rohrbach E, Schmid R, Verloo H. Recommendations for prevention, diagnostic and therapy of delirium in the elderly. Praxis (Bern 1994) 2016

von Gunten A, Baumgartner M, Georgescu D, Hafner M, Hasemann W. Kressig RE, Popp J, Rohrbach E, Schmid R, Verloo H, Savaskan E. Prévention, diagnostic et prise en soin de l’état confusionnel aigu de la personne âgée. Swiss Medical Forum. 2017 in press

Bürge M, Bieri G, Brühlmeier M, Colombo F, Demonet JF, Felbecker A, Georgescu D, Gietl A, Brioschi Guevara A, Jüngling F, Kirsch E, Kressig RW, Kulic L, Monsch AU, Ott M, Pihan H, Popp J, Rampa L, Rüegger-Frey B, Schneitter M, Unschuld PG, von Gunten A, Weinheimer B, Wiest R, Savaskan E. Die Empfehlungen der Swiss Memory Clinics für die Diagnostik der Demenzerkrankungen Swiss Memory Clinics Recommendations for the Diagnosis of Dementia. Praxis (Bern 1994) 2018 in press

Books

Savaskan E, Baumgartner M, Georgescu D, Hafner M, Hasemann W. Kressig RE, Popp J Rohrbach E, Schmid R, Verloo H. Das Delir-Manual. Hogrefe 2016

 

top